These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23580324)

  • 1. Expression of p15INK⁴b and p57KIP² and relationship with clinicopathological features and prognosis in patients with vulvar squamous cell carcinoma.
    Holm R; Førsund M; Nguyen MT; Nesland JM; Trope CG
    PLoS One; 2013; 8(4):e61273. PubMed ID: 23580324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors.
    Endo M; Kobayashi C; Setsu N; Takahashi Y; Kohashi K; Yamamoto H; Tamiya S; Matsuda S; Iwamoto Y; Tsuneyoshi M; Oda Y
    Clin Cancer Res; 2011 Jun; 17(11):3771-82. PubMed ID: 21262917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A potential role for p15(Ink4b) and p57(Kip2) in liver development.
    Awad MM; Sanders JA; Gruppuso PA
    FEBS Lett; 2000 Oct; 483(2-3):160-4. PubMed ID: 11042273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of p16(INK4a)/p14(ARF) locus deletion and MDM-2 protein expression in adult acute myelogenous leukemia.
    Faderl S; Kantarjian HM; Estey E; Manshouri T; Chan CY; Rahman Elsaied A; Kornblau SM; Cortes J; Thomas DA; Pierce S; Keating MJ; Estrov Z; Albitar M
    Cancer; 2000 Nov; 89(9):1976-82. PubMed ID: 11064355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of p15 and p15.5 products in neuroendocrine lung tumours: relationship with p15(INK4b) methylation status.
    Chaussade L; Eymin B; Brambilla E; Gazzeri S
    Oncogene; 2001 Oct; 20(45):6587-96. PubMed ID: 11641784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CDK1(Tyr15), pCDK1(Thr161), Cyclin B1 (total) and pCyclin B1(Ser126) in vulvar squamous cell carcinoma and their relations with clinicopatological features and prognosis.
    Wang Z; Slipicevic A; Førsund M; Trope CG; Nesland JM; Holm R
    PLoS One; 2015; 10(4):e0121398. PubMed ID: 25849598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of the INK4A and INK4B gene loci in human breast cancer cell lines and primary carcinomas.
    Bisogna M; Calvano JE; Ho GH; Orlow I; Cordón-Cardó C; Borgen PI; Van Zee KJ
    Cancer Genet Cytogenet; 2001 Mar; 125(2):131-8. PubMed ID: 11369056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SH3GL2 and CDKN2A/2B loci are independently altered in early dysplastic lesions of head and neck: correlation with HPV infection and tobacco habit.
    Ghosh A; Ghosh S; Maiti GP; Sabbir MG; Alam N; Sikdar N; Roy B; Roychoudhury S; Panda CK
    J Pathol; 2009 Feb; 217(3):408-19. PubMed ID: 19023882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of the p14(ARF), p15(INK4B) and p16(INK4A) genes is a frequent event in human oral squamous cell carcinomas.
    Shintani S; Nakahara Y; Mihara M; Ueyama Y; Matsumura T
    Oral Oncol; 2001 Sep; 37(6):498-504. PubMed ID: 11435176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma.
    Chinnasri P; Pairojkul C; Jearanaikoon P; Sripa B; Bhudhisawasdi V; Tantimavanich S; Limpaiboon T
    Hum Pathol; 2009 Jun; 40(6):817-26. PubMed ID: 19200577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Cell Cycle Regulators
    El-Salahy E; Abou-Ghalia AH; Adli A; Kassim SK
    Cancer Genomics Proteomics; 2005; 2(4):239-245. PubMed ID: 31394712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque.
    Holdt LM; Sass K; Gäbel G; Bergert H; Thiery J; Teupser D
    Atherosclerosis; 2011 Feb; 214(2):264-70. PubMed ID: 20637465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of cell-cycle regulators and cellular biomarkers in laryngeal squamous cell carcinoma.
    Swellam M; El-Arab LR; Adly A
    Clin Biochem; 2008 Sep; 41(13):1059-66. PubMed ID: 18602381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival.
    Nakai S; Masaki T; Shiratori Y; Ohgi T; Morishita A; Kurokohchi K; Watanabe S; Kuriyama S
    Int J Oncol; 2002 Apr; 20(4):769-75. PubMed ID: 11894123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
    Watanabe T; Katayama Y; Yoshino A; Komine C; Yokoyama T
    Clin Cancer Res; 2003 Oct; 9(13):4884-90. PubMed ID: 14581362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of p57(Kip2) down-regulation in oncogenesis of bladder carcinoma: an immunohistochemical study.
    Bozdoğan O; Atasoy P; Batislam E; Başar MM; Başar H
    Tumori; 2008; 94(4):556-62. PubMed ID: 18822693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of methylated p15 and p16 genes on clinicopathological features in colorectal cancer.
    Ishiguro A; Takahata T; Saito M; Yoshiya G; Tamura Y; Sasaki M; Munakata A
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1334-9. PubMed ID: 16872319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphovascular invasion and p16 expression are independent prognostic factors in stage I vulvar squamous cell carcinoma.
    Davidson B; Skeie-Jensen T; Holth A; Lindemann K; Toralba Barrameda AM; Lie AK; Wang Y
    Virchows Arch; 2024 Jun; 484(6):951-963. PubMed ID: 37843640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p57(kip2) expression is related to carcinogenesis and tumor progression in laryngeal tissues.
    Fan GK; Xu F; Yang B; Fujieda S
    Acta Otolaryngol; 2006 Mar; 126(3):301-5. PubMed ID: 16618659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of p14ARF, p15INK4b, p16INK4a, and DCR2 increases during prostate cancer progression.
    Zhang Z; Rosen DG; Yao JL; Huang J; Liu J
    Mod Pathol; 2006 Oct; 19(10):1339-43. PubMed ID: 16799475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.